1. Home
  2. PLRX vs FPI Comparison

PLRX vs FPI Comparison

Compare PLRX & FPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • FPI
  • Stock Information
  • Founded
  • PLRX 2015
  • FPI 2013
  • Country
  • PLRX United States
  • FPI United States
  • Employees
  • PLRX N/A
  • FPI N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • FPI Real Estate Investment Trusts
  • Sector
  • PLRX Health Care
  • FPI Real Estate
  • Exchange
  • PLRX Nasdaq
  • FPI Nasdaq
  • Market Cap
  • PLRX 680.3M
  • FPI 607.9M
  • IPO Year
  • PLRX 2020
  • FPI 2014
  • Fundamental
  • Price
  • PLRX $11.61
  • FPI $11.71
  • Analyst Decision
  • PLRX Strong Buy
  • FPI
  • Analyst Count
  • PLRX 7
  • FPI 0
  • Target Price
  • PLRX $40.50
  • FPI N/A
  • AVG Volume (30 Days)
  • PLRX 485.5K
  • FPI 241.0K
  • Earning Date
  • PLRX 02-26-2025
  • FPI 02-26-2025
  • Dividend Yield
  • PLRX N/A
  • FPI 11.97%
  • EPS Growth
  • PLRX N/A
  • FPI N/A
  • EPS
  • PLRX N/A
  • FPI 0.32
  • Revenue
  • PLRX N/A
  • FPI $58,465,000.00
  • Revenue This Year
  • PLRX N/A
  • FPI N/A
  • Revenue Next Year
  • PLRX N/A
  • FPI N/A
  • P/E Ratio
  • PLRX N/A
  • FPI $36.15
  • Revenue Growth
  • PLRX N/A
  • FPI 1.30
  • 52 Week Low
  • PLRX $10.22
  • FPI $9.70
  • 52 Week High
  • PLRX $18.00
  • FPI $12.85
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 47.63
  • FPI 50.23
  • Support Level
  • PLRX $10.35
  • FPI $11.40
  • Resistance Level
  • PLRX $11.07
  • FPI $11.78
  • Average True Range (ATR)
  • PLRX 0.55
  • FPI 0.22
  • MACD
  • PLRX 0.11
  • FPI 0.02
  • Stochastic Oscillator
  • PLRX 55.75
  • FPI 66.07

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, citrus, blueberries, and vegetables. The company generates its revenues through the rent it receives from its tenants.

Share on Social Networks: